Literature DB >> 8747948

Intramedullary spinal cord tumors in neurofibromatosis.

M Lee1, A R Rezai, D Freed, F J Epstein.   

Abstract

Neurofibromatosis (NF) describes the most commonly inherited disorders affecting the nervous system. These autosomal dominant, neurocutaneous syndromes are associated with multiple tumors of the nervous system, including neurofibromas, schwannomas, meningiomas, and intracranial gliomas. Spinal cord involvement in NF is typically from extramedullary growth of spinal nerve root tumors. Intramedullary spinal cord tumors in NF have been reported as scattered, single cases in literature. However, this association has not been clearly defined as have other nervous system neoplasms that are typically linked with NF. We present a series of nine patients with NF with intramedullary spinal cord tumors who were managed at our institution from 1984 to 1994. The patients' ages ranged from 4 to 31 years. There were seven male patients and two female patients. Three patients had NF-1 (von Recklinghausen's), five patients had NF-2, and one patient had NF, type uncertain. There were three cervicomedullary tumors, two cervical tumors, three cervicothoracic tumors, and one thoracic tumor. A histological examination revealed five ependymomas, three astrocytomas, and one intramedullary schwannoma. Two patients with malignant intramedullary spinal ocrd tumors have died with progressive disease. One other patient has required a subsequent operation for recurrent tumor. The other six patients are doing well, and their prognosis is expected to be related to their systemic disease. We conclude that there is a clinical entity of intramedullary spinal cord tumors associated with NF.

Entities:  

Mesh:

Year:  1996        PMID: 8747948     DOI: 10.1097/00006123-199601000-00009

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

Review 1.  Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Authors:  A T Parsa; A J Fiore; P C McCormick; J N Bruce
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

Review 3.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

Review 4.  Spinal manifestations of Neurofibromatosis type 1.

Authors:  Ben Shofty; Ori Barzilai; Morsi Khashan; Zvi Lidar; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-20       Impact factor: 1.475

Review 5.  Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature.

Authors:  Dolly G Aguilera; Claire Mazewski; Matthew J Schniederjan; Traci Leong; William Boydston; Tobey J Macdonald
Journal:  Childs Nerv Syst       Date:  2010-12-04       Impact factor: 1.475

Review 6.  Charcot-Marie-Tooth syndrome and neurofibromatosis type 1 with multiple neurofibromas of the entire spinal nerve roots.

Authors:  David O Onu; Andrew W Hunn; Jens Peters-Willke
Journal:  BMJ Case Rep       Date:  2013-07-13

Review 7.  Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis.

Authors:  T H Schwartz; P C McCormick
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 8.  Spinal cord astrocytomas: presentation, management and outcome.

Authors:  J K Houten; P R Cooper
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

9.  Ganglioglioma of conus medullaris in a patient of neurofibromatosis type 1: A novel association?

Authors:  Ilangovan Vijay Sundar; Manish Jaiswal; Devendra Purohit; R S Mittal
Journal:  Asian J Neurosurg       Date:  2016 Oct-Dec

Review 10.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.